Video Buzz v1

RelatedLinks

December 21st

• Metastatic Breast Cancer Patients With Poor Performance Status Respond Well to Ixabepilone Plus Capecitabine: Presented at SABCS: For patients with metastatic breast cancer who have poor performance status and who show resistance to anthracyclines and taxanes, ixabepilone plus capecitabine improves overall survival, progression-fr ee survival, and tumor response compared with capecitabine alone, according to results of 2 large phase 3 studies, presented at the 31st Annual San Antonio Breast Cancer Symposium (SABCS).

December 9th

• Competitor - Ixempra - Pfizer - against breast cancer tumors resistant or refractory to anthracyclines , taxanes, and capecitabine: IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicate d. Anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting. Taxane resistance is defined as progression while on therapy or within 12 months in the adjuvant setting or 4 months in the metastatic setting.

December 1st

• Cardiotoxicity and Cardiomyopathy
• Medical News: Progressive Heart Damage Seen Two Decades After Adriamycin - in Cardiovascular , CHF from MedPage Today

October 9th

• Chemotherapy boosts heart disease risk - 10/08/2007 - MiamiHerald.co m

RelatedImages

No Images Available!

Video Buzz > Anthracyclines

Video Buzz Video Player :)

No Matching Video

No video for Anthracyclines is available at this time.

Related Anthracyclines News

Anthracyclines Podcasts

Do you prefer to listen to your anthracyclines gossip? Check out Podzy Podcast Directory > Anthracyclines.

Anthracyclines Products

Looking for anthracyclines related products, then look no further. Try our new Anthracyclines Shop.